Dissolution Method Development

Dissolution method development establishes standardised procedures measuring pharmaceutical active ingredient release rates supporting bioavailability prediction. Apparatus selection including paddle, basket, and flow-through designs matches anticipated gastrointestinal conditions. Medium composition incorporating pH, surfactant, and buffer systems reflects physiological environment. Solubility assessment determines whether sink conditions exist ensuring valid results.

Instrument qualification protocols verify apparatus appropriateness and suitability. Method validation demonstrates accuracy, precision, and discriminatory power. Supersaturation and precipitation phenomena in low-pH media complicate testing for poorly soluble drugs. Biorelevant media incorporating physiological components enhance predictive value. Regulatory submissions justify method appropriateness supporting bioequivalence conclusions.